Bumrungrad Hospital Public Company Limited (SET: BH) has announced its 3Q24 consolidated financial statement through the Stock Exchange of Thailand as follows:
| Quarter | 3Q24 | 3Q23 |
| Net Profit (Loss)
Million Baht |
1,955.14 | 1,954.43 |
| Earning Per Share
(Baht) |
2.4600 | 2.4600 |
| % Change | 0.04 | |
| 9 Months | 2024 | 2023 |
| Net Profit (Loss)
Million Baht |
5,871.77 | 5,285.62 |
| Earning Per Share (Baht) | 7.3900 | 6.6500 |
| % Change | 11.09 | |
BH reported a net profit in 3Q24 of Baht 1,955 million, slightly up from Baht 1,954 million in 3Q23, resulting in a Net profit margin of 30.3% for 3Q24, compared to 28.8% in 3Q23. Total revenues stood at Baht 6,447 million, a 4.9% decrease from Baht 6,775 million in 3Q23.
The company reported revenues from hospital operations of Baht 6,384 million in 3Q24, a 5.0% decrease year-over-year from Baht 6,720 million in 3Q23. This was mostly due to a decrease in revenues from non-Thai and Thai patients by 6.8% and 1.4%, respectively. As a result, the revenue contribution from Thai patients was 34.3%, whereas revenue from non-Thai patients was 65.7% in 3Q24 compared with 33.1% and 66.9%, respectively, in 3Q23.
Cost of hospital operations (including depreciation and amortization) was at Baht 3,089 million in 3Q24, reflecting an 8.4% decrease from Baht 3,371 million in 3Q23. This represented a favorable change compared to the 5.0% decrease in revenues from hospital operations, leading to a reduction in the percentage of cost to revenues from hospital operations to 48.4% in 3Q24 from 50.2% in 3Q23.
